Acropolis Investment Management’s Roivant Sciences ROIV Stock Holding History

Acropolis Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$134K	Buy	+3,666	New	+$133K	0.01%	336

Other funds holding ROIV

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Acropolis Investment Management's ROIV Position: Q3 2026 in Review

Acropolis Investment Management opened a new position in Roivant Sciences (ROIV) in Q3 2026: 3,666 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #336 among its holdings.

20 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

Acropolis Investment Management held 3,666 shares of Roivant Sciences worth $134K as of Q3 2026.
Roivant Sciences was a new Acropolis Investment Management position in Q3 2026.
Roivant Sciences made up 0.01% of Acropolis Investment Management's portfolio in Q3 2026, its #336 holding.
20 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Acropolis Investment Management's 13F filing for Q3 2026, filed 8 Oct 2026.